MILIND JAVLE to Matrix Metalloproteinase Inhibitors
This is a "connection" page, showing publications MILIND JAVLE has written about Matrix Metalloproteinase Inhibitors.
Connection Strength
0.019
-
A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors. Clin Cancer Res. 2007 Apr 01; 13(7):2091-9.
Score: 0.019